Glaucoma genetics study in Sohag University Hospital
Part of Eyes & vision clinical trials.
This study looks at whether a certain gene (MMP-9) is linked to primary open-angle glaucoma in people over 30. It compares glaucoma patients with healthy volunteers to find possible genetic risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 30 years old
- You have been diagnosed with primary open-angle glaucoma (with vision loss and optic nerve changes)
- Or you are a healthy person of similar age, sex, and background for comparison
- You do not have exfoliation or pigmentary glaucoma
- You have no history of sudden angle-closure glaucoma
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well your side (peripheral) vision helps you understand what you see in everyday scenes. It compares people with stable glaucoma to people without eye diseases, to learn which parts of vision and attention matter most.
This trial tests a gene therapy treatment called GVB-2001 for people with primary open angle glaucoma. It involves a one-time injection into the eye to help lower eye pressure, and could be an option if you have tried other treatments that haven't worked well enough.
This study collects eye fluid and tissue samples during planned cataract or combined cataract-glaucoma surgery to analyze differences between people with and without glaucoma. It may help researchers understand eye disease better.
This study looks at the different types of eye diseases in people who visit the eye testing unit. It helps doctors understand what conditions are most common so they can improve care.
This study looks at blood or DNA-related factors that may explain why certain glaucoma and related eye conditions happen. It may help researchers understand risk and causes across different glaucoma types.
This study follows people with a genetic form of optic atrophy over time to understand how vision changes. It does not test a treatment but helps doctors learn more about the condition to improve care.
Hear when a new Primary Open Angle Glaucoma (POAG) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.